Raymond James Starts BioMarin Pharmaceutical Inc. (BMRN) at Market Perform, 'Cautious on Roctavian's Outlook & Few Near-Term Catalysts'
Tweet Send to a Friend
(Updated - September 28, 2023 6:27 AM EDT)
Raymond James analyst Danielle Brill initiates coverage on BioMarin Pharmaceutical Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Danielle Brill initiates coverage on BioMarin Pharmaceutical Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
